Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
NOTCH3 VHH recombinant monoclonal antibody
NRP1 VHH recombinant monoclonal antibody
NT5E VHH recombinant monoclonal antibody
OSMR VHH recombinant monoclonal antibody
PDGFRA VHH recombinant monoclonal antibody
PDGFRB VHH recombinant monoclonal antibody
PDL1 VHH recombinant monoclonal antibody
PRLR VHH recombinant monoclonal antibody
PTPRC VHH recombinant monoclonal antibody
PVRL4 VHH recombinant monoclonal antibody
RGMA VHH recombinant monoclonal antibody
RHD VHH recombinant monoclonal antibody